New Deal forced the investment type of medical reform and innovation in business models.doc

New Deal forced the investment type of medical reform and innovation in business models.doc

  1. 1、本文档共8页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
New Deal forced the investment type of medical reform and innovation in business models

 PAGE \* MERGEFORMAT 8 New Deal forced the investment type of medical reform and innovation in business models Pharmaceutical commercial enterprises on the current, limited by the product of factors is still quite obvious, while investment in the important role of pharmaceutical companies in the self-evident. With the gradual implementation of new health care reform, both at different levels indicates that the existing systems of medicine will produce a series of shocks. rely on investment model for the survival of all levels of business, how to deal with this situation, it is particularly important. Changes in business management How do changes in the new round of market development in good shape and improve their market competitiveness, we need to market and channel development from the basic set, follow the changes of the times to change. A new era, we must take the “new investment” in Way! Especially new product as the core business-type investment companies, are facing more intense market competition. Investment enterprises to sustain development, in addition to a reasonable number of stars to create products, but also appropriate for existing products and timely adjustment and improvement. The existing manufacturers, in order to sell more products to every corner of the market has been moving away from previous nationwide packet mode, to the regional agency, channels, agents, model agents, and other specifications. so do the manufacturers can maximize the increase in terms of sales, but to rely on new product investment in commercial enterprises is indeed a challenge. Regional agency and the agency reduced the investment channels for the survival of enterprises, while the same product specifications and more sales of the market, then disrupt the normal sales order, and the other to the core of the pharmaceutical investment business enterprises on the miserable. On the current pharmaceutical business enterprises , the constraints are still quite

文档评论(0)

jiupshaieuk12 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档